PSYCH up2date, Table of Contents PSYCH up2date 2014; 8(01): 21-36DOI: 10.1055/s-0033-1359955 Angststörungen, Zwangsstörungen und stressassoziierte Störungen Störungsspezifische Therapie der Zwangsstörungen Ulrich Voderholzer , Maike Müller , Anne Katrin Külz Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Wittchen HU, Jacobi C. DEGS Studie zur Gesundheit Erwachsener in Deutschland: Was sind die häufigsten psychischen Störungen in Deutschland?. Berlin: Robert Koch-Institut; 2012 2 Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Archives of General Psychiatry 1999; 56: 121-127 3 Voderholzer U, Hohagen F. Therapie psychischer Erkrankungen: State of the Art 2010/2011. 6. Aufl. München: Urban & Fischer, Elsevier; 2011: 414-415 4 Förstner U, Külz AK, Voderholzer U. Störungsspezifische Behandlung der Zwangsstörungen: Ein Therapiemanual. Stuttgart: Kohlhammer; 2011 5 Olatunji BO, Davis ML, Powers MB. et al. Cognitive-behavioral therapy for obsessive-compulsive disorder: A meta-analysis of treatment outcome and moderators. J Psychiatric Res 2013; 47: 33-41 6 Soomro GM, Altman D, Rajagopal S. et al. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008; 1: CD001765 7 Karno M, Golding JM, Sorenson SB. et al. The epidemiology of obsessive-compulsive disorder in five US communities. Arch General Psychiatry 1988; 45: 1094-1099 8 Hertenstein E, Thiel N, Herbst N. et al. Quality of life changes following inpatient and outpatient treatment in obsessive-compulsive disorder: a study with 12 months follow-up. Ann Gen Psychiatry 2013; 12: 4 9 WHO. Dilling H, Mombour W, Schmidt MH. Hrsg. Internationale Klassifikation psychischer Störungen. Vol. 4. Bern: Verlag Hans Huber; 2000 10 Goodman WK, Price LH, Rasmussen SA. et al. The Yale-Brown Obsessive Compulsive Scale. Arch Gen Psychiatry 1989; 46: 1006-1011 11 Abramowitz JS, Deacon BJ. Psychometric properties and construct validity of the Obsessive-Compulsive Inventory-Revised: Replication and extension with a clinical sample. J Anxiety Disorders 2006; 20: 1016-1035 12 Jacobsen D, Kloss M, Fricke S. et al. Reliabilität der deutschen Version der Yale-Brown Obsessive Compulsive Scale. Verhaltenstherapie 2003; 13: 111-113 13 Nestadt G, Bienvenu OJ, Cai G. et al. Incidence of obsessive-compulsive disorder in adults. J Nerv Ment Dis 1998; 186: 401-406 14 Voderholzer U, Riemann D, Huwig-Poppe C. et al. Sleep in obsessive compulsive disorder: polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency. Eur Arch Psychiatry Clin Neurosci 2007; 257: 173-182 15 Thiel N, Hertenstein E, Nissen C. et al. The effect of personality disorders on treatment outcomes in patients with obsessive-compulsive disorders. J Personality Disorders 2013; 27: 697-715 16 Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRIs. Br J Psychiatry 1998; 173 (Suppl. 35) 7-12 17 Grabe HJ, Ruhrmann S, Ettelt S. et al. Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects. Am J Psychiatry 2006; 163: 1986-1992 18 Schirmbeck F, Esslinger C, Rausch F. et al. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychological Med 2011; 41: 2361-2373 19 Maier S, Kuelz AK, Voderholzer U. Traumatisierung und Dissoziationsneigung bei Zwangserkrankten: Ein Überblick. Verhaltenstherapie 2009; 19: 219-227 20 Obsessive Compulsive Cognitions Working Group (OCCWG). Cognitive assessment of obsessive-compulsive disorder. Behav Res Ther 1997; 35: 667-681 21 Kuelz AK, Voderholzer U. [Psychotherapy for obsessive-compulsive disorder: what is evidence based?. ] Nervenarzt 2011; 82: 308-310,312,314-316 22 Walitza S, Melfsen S, Jans T. et al. Zwangsstörung im Kindes- und Jugendalter. Dtsch Arztebl International 2011; 108: 173-179 23 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Kordon A. et al. S3 Leitlinie Zwangsstörungen. Accessed December 18, 2013 at: http://www.awmf.org/uploads/tx_szleitlinien/038_017l_S3_Zwangsstörungen_2013.pdf 24 Lakatos A, Reinecker H. Kognitive Verhaltenstherapie bei Zwangsstörungen. Ein Therapiemanual. 3. Aufl. Göttingen: Hogrefe; 2007 25 Foa EB, Liebowitz MR, Kozak MJ. et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005; 162: 151-161 26 Jaurrieta N, Jiménez-Murcia S, Alonso P. et al. Individual versus group cognitive behavioral treatment for obsessive-compulsive disorder: Follow up. Psychiatry Clin Neurosci 2008; 62: 697-704 27 Cottraux J, Mollard E, Bouvard M. et al. Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: One-year followup. Psychiatry Res 1993; 49: 63-75 28 Salkovskis PM. Understanding and treating obsessive-compulsive disorder. Behaviour Res Ther 1999; 37 (Suppl. 01) S29-S52 29 Kulz AK, Rose N. [Mindfulness Based Cognitive Therapy (MBCT) in patients with obsessive-compulsive disorder – an adaptation of the original program]. Psychother Psychosom Med Psychol 2013; (in press) 0 30 Twohig MP, Hayes SC, Plumb JC. et al. A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. J Consult ClinPsychol 2010; 78: 705-716 31 Piccinelli M, Pini S, Bellantuono C. et al. Efficacy of drug treatment in obsessive-compulsive disorder: A meta-analytic review. Br J Psychiatry 1995; 166: 424-443 32 Phelps NJ, Cates ME. The role of venlafaxine in the treatment of obsessive-compulsive disorder. Ann Pharmacotherapy 2005; 39: 136-140 33 Koran LM, Hanna GL, Hollander E. et al. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007; 164: 5-53 34 Ninan PT, Koran LM, Kiev A. et al. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. J Clin Psychiatry 2006; 67: 15-22 35 Kordon A, Kahl KG, Broocks A. et al. Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up. Eur Arch Psychiatry Clin Neurosci 2005; 255: 48-50 36 Greenberg BD, Gabriels LA, Malone Jr DA. et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry 2010; 15: 64-79 37 Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia – Clinical characteristics and treatment. Cns Drugs 2004; 18: 989-1010 38 Freeman JB, Choate-Summers ML, Moore PS. et al. Cognitive behavioral treatment for young children with obsessive-compulsive disorder. Biol Psychiatry 2007; 61: 337-343 39 Dtsch Gesellschaft für Kinder- und Jugendpsychiatrie. Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. Köln: Deutscher Ärzte Verlag; 2007
